Abstract
Deep brain stimulation (DBS) is an established treatment for Parkinson’s disease. Still, DBS parameter programming currently follows a tedious trial-and-error process. DBS-evoked cortical potentials (EP) might guide parameter selection but this concept has not yet been tested. Further, mounting wet EEG systems is too time-consuming to scale in outpatient clinic settings. Here, we test the utility of a novel method that leverages the spatial pattern of EP using a dry EEG setup. We acquired EP in 58 hemispheres in patients with Parkinson’s disease and compute a model which represents the optimal EP response pattern associated with maximal clinical improvements. Once defined, we use this pattern to estimate stimulation outcomes in unseen patients. Finally, we utilize it to identify optimal stimulation contacts in five unseen hemispheres where it selected the correct contact in all cases. The simple setup makes this novel method an attractive option to guide DBS programming in clinical practice.
Competing Interest Statement
A.H. reports lecture fees for Boston Scientific and is a consultant for FxNeuromodulation and Abbott. All other authors do not report competing interests relevant to this work.
Funding Statement
This work was supported by the Deutsches Zentrum fur Luft-und Raumfahrt (DynaSti grant within the EU Joint Programme Neurodegenerative Disease Research, JPND). BHB and LLG gratefully acknowledge support by the Prof. Dr. Klaus Thiemann Foundation (Parkinson Fellowship 2022 and 2023). A.H. was supported by National Institutes of Health (R01MH130666, 1R01NS127892-01, 2R01 MH113929 & UM1NS132358) as well as the New Venture Fund (FFOR Seed Grant). GW acknowledges support by Deutsche Forschungsgemeinschaft (DFG) Project number 424778381 (TRR 295) and Project number 511192033. EF received funding from the Deutsche Forschungsgemeinschaft (CRC 295, FL 760/6-1) and Volkswagen foundation (Lichtenberg program).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee at Charite - Universitatsmedizin Berlin gave ethical approval for this work (Ethic proposal number EA2/247/21).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
